7-144129251-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001659.3(OR2A14):c.139A>T(p.Ile47Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000357 in 1,613,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001659.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2A14 | NM_001001659.3 | c.139A>T | p.Ile47Phe | missense_variant | 2/2 | ENST00000641068.1 | NP_001001659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2A14 | ENST00000641068.1 | c.139A>T | p.Ile47Phe | missense_variant | 2/2 | NM_001001659.3 | ENSP00000493353 | P1 | ||
OR2A14 | ENST00000408899.2 | c.139A>T | p.Ile47Phe | missense_variant | 1/1 | ENSP00000386137 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000211 AC: 32AN: 151568Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000220 AC: 55AN: 249560Hom.: 0 AF XY: 0.000251 AC XY: 34AN XY: 135392
GnomAD4 exome AF: 0.000372 AC: 544AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.000360 AC XY: 262AN XY: 727224
GnomAD4 genome AF: 0.000211 AC: 32AN: 151568Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.139A>T (p.I47F) alteration is located in exon 1 (coding exon 1) of the OR2A14 gene. This alteration results from a A to T substitution at nucleotide position 139, causing the isoleucine (I) at amino acid position 47 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at